2025
Misoprostol administration mimicking a febrile transfusion reaction
Yurtsever N, Snyder E. Misoprostol administration mimicking a febrile transfusion reaction. Transfusion 2025, 65: 643-646. PMID: 39907501, DOI: 10.1111/trf.18150.Peer-Reviewed Original ResearchConceptsFebrile nonhemolytic transfusion reactionsTransfusion reactionsBlood culturesSynthetic prostaglandin E1 analogueThermogenic effectAdministration of misoprostolProstaglandin E1 analogueRed cell transfusionTransfusion medicineFebrile transfusion reactionsNonhemolytic transfusion reactionsG1P0 femaleMisoprostol administrationCell transfusionE1 analogueChart reviewSerological workupCase reportDifferential diagnosisEnhance patient satisfactionMisoprostolTransfusionUterotonic propertiesSerological findingsSide effects
2023
Assessing Recommendations for Determining Fetal Risk in Alloimmunized Pregnancies in the United States: Is It Time to Update a Decades-Old Practice?
Abels E, Adkins B, Cedeno K, Booth G, Allen E, Stephens L, Woo J, Tormey C, Jacobs J. Assessing Recommendations for Determining Fetal Risk in Alloimmunized Pregnancies in the United States: Is It Time to Update a Decades-Old Practice? Transfusion Medicine Reviews 2023, 38: 150810. PMID: 38194730, DOI: 10.1016/j.tmrv.2023.150810.Peer-Reviewed Original ResearchAntigen testingEvidence-based recommendationsFetal risksAlloimmunized pregnanciesPoor outcomeHemolytic diseasePractice guidelinesDecades-old practiceNarrative reviewTransfusion medicineUnnecessary riskRecent evidencePregnancyUnited StatesFetusesRiskCurrent United StatesValuable alternativeTesting algorithmObstetriciansCurrent landscapeDiseaseRecommendations
2020
Chapter 2 Methods of RBC Alloimmunization to ABO and Non-ABO Antigens, and Test Methodologies
Stendahl K, Tormey C, Baine I. Chapter 2 Methods of RBC Alloimmunization to ABO and Non-ABO Antigens, and Test Methodologies. 2020, 15-33. DOI: 10.1016/b978-0-323-67509-3.00002-0.ChaptersRBC alloimmunizationRBC transfusionRBC antigensHematopoietic progenitor cell transplantCompatible blood productsCompatible RBC unitsIncompatible RBC transfusionHemolytic transfusion reactionsProgenitor cell transplantABO blood groupComplex clinical scenariosCell transplantABO compatibilityMolecular typing methodsTransfusion reactionsBlood productsSolid organsImmunologic conceptsClinical scenariosAntibody detectionRBC unitsAntigenPatientsBlood groupTransfusion medicine
2019
64 Platelet Transfusion Medicine
Siddon A, Tormey C, Snyder E. 64 Platelet Transfusion Medicine. 2019, 1137-1159. DOI: 10.1016/b978-0-12-813456-6.00064-3.ChaptersPlatelet transfusion practicesBone marrow transplantationPlatelet function defectsPathogen inactivation technologiesImmune thrombocytopeniaAcute bleedingCardiac surgeryMassive transfusionMarrow transplantationPlatelet transfusionsTransfusion practiceTransfusion reactionsClinical circumstancesStorage of PCsClinical careFunction defectsTransfusionPlatelet physiologyTransfusion medicinePlatelet preparationsThrombocytopeniaInactivation technologiesBacterial contaminationNumerous advancesSpecial considerationChapter 49 Neonatal and Pediatric Transfusion Medicine
Zerra P, Hendrickson J, Josephson C. Chapter 49 Neonatal and Pediatric Transfusion Medicine. 2019, 295-299. DOI: 10.1016/b978-0-12-813726-0.00049-0.Peer-Reviewed Original ResearchChapter Six The chemical and laboratory investigation of hemolysis
Siddon AJ, Tormey CA. Chapter Six The chemical and laboratory investigation of hemolysis. Advances In Clinical Chemistry 2019, 89: 215-258. PMID: 30797470, DOI: 10.1016/bs.acc.2018.12.006.Peer-Reviewed Original ResearchConceptsRed blood cellsSignificant clinical issueDivision of HematologyLaboratory investigationsPathophysiology of hemolysisPrimary disorderDisease processHemolytic disordersClinical issuesPathologic formsClinical pathologyBlood cellsTransfusion medicineClinical interpretationHemolysisClinical laboratoriesClinical chemistryLaboratory basisDisordersAssaysAbnormal breakdownPathophysiologyPathologyHematology
2018
Transfusion Medicine Equations Made Internet Accessible
Charifa A, Ryder A, Cheng C, Tormey C, Hauser R. Transfusion Medicine Equations Made Internet Accessible. American Journal Of Clinical Pathology 2018, 150: s141-s141. DOI: 10.1093/ajcp/aqy105.336.Peer-Reviewed Original Research
2014
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders
Gehrie EA, Tormey CA. The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders. Transfusion Medicine And Hemotherapy 2014, 41: 420-429. PMID: 25670929, PMCID: PMC4280450, DOI: 10.1159/000369109.Peer-Reviewed Original ResearchRed blood cellsPatient populationInfluence of ClinicalDevelopment of antibodiesImportant clinical consequencesDiverse patient populationsBlood group antigensRBC alloimmunizationChronic transfusionRBC alloantibodiesHyper respondersClinical circumstancesClinical consequencesAlloimmunizationMedical literatureTransfusionAlloantibodiesGroup antigensRespondersBlood cellsTransfusion medicinePatientsBiological factorsIndividualsPregnancy
2013
Chapter 47 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 47 Neonatal and Pediatric Transfusion Medicine. 2013, 301-305. DOI: 10.1016/b978-0-12-397164-7.00047-1.Peer-Reviewed Original ResearchChapter 62 Platelet Transfusion Medicine
Perrotta P, Parsons J, Rinder H, Snyder E. Chapter 62 Platelet Transfusion Medicine. 2013, 1275-1303. DOI: 10.1016/b978-0-12-387837-3.00062-6.Peer-Reviewed Original ResearchPlatelet transfusionsThrombocytopenic patientsTransfusion-related acute lung injuryTransfusion-transmitted viral infectionsAdverse effectsAcute lung injuryCommon adverse effectsPlatelet transfusion therapyLung injuryTransfusion therapyThrombocytopenic bleedingBlood therapyTransfusion reactionsBlood productsAllergic reactionsClinical experienceViral infectionTransfusionTransfusion medicineWhole bloodSeptic reactionsBleedingCell separatorPatientsTherapy
2012
The transfusion medicine specialist as a coagulation consultant: a new variant of therapeutic pathology
Tormey CA, Smith BR. The transfusion medicine specialist as a coagulation consultant: a new variant of therapeutic pathology. Transfusion 2012, 53: 2086-2093. PMID: 23228202, DOI: 10.1111/trf.12012.Peer-Reviewed Original ResearchConceptsTransfusion medicine practitionersMedicine practitionersTransfusion medicineLaboratory coagulation testingRegular clinical practicePatient managementClinical roleCoagulation testingClinical practiceClinical issuesHemostasisShortage of specialistsField of hemostasisConsultationNovel curriculumMedicineThrombosisDiagnosis, Treatment, and Reporting of Adverse Effects of Transfusion
Torres R, Kenney B, Tormey C. Diagnosis, Treatment, and Reporting of Adverse Effects of Transfusion. Lab Medicine 2012, 43: 217-231. DOI: 10.1309/lm3naabjjk1hnyfu.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsTransfusion reactionsAdverse transfusion eventsMild transfusion reactionRisk of transfusionPulmonary complicationsTransfusion eventsClinical featuresAnaphylactic reactionsFebrile responseClinical dilemmaTransfusionHemolytic reactionTransfusion medicineAdverse effectsSeptic reactionsDiagnosisCurrent understandingComplicationsEtiologyIncidencePreventionReporting
2010
Use of mouse models to study the mechanisms and consequences of RBC clearance
Hod E, Arinsburg S, Francis R, Hendrickson J, Zimring J, Spitalnik S. Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sanguinis 2010, 99: 99-111. PMID: 20345515, PMCID: PMC3580149, DOI: 10.1111/j.1423-0410.2010.01327.x.Peer-Reviewed Original ResearchConceptsMouse modelRBC clearanceImmune globulin therapyAutoimmune haemolytic anaemiaHaemolytic transfusion reactionsGlobulin therapyRBC transfusionTransfusion reactionsHaemolytic anaemiaAnimal modelsTractable animal modelTransfusion medicineCell clearanceClearancePathophysiologyHuman disordersUnanswered questionsTransfusionComplicationsAnemiaImmunomodulationTherapyMiceAntibodies
2009
Clinical trials for pathogen reduction in transfusion medicine: A review
McClaskey J, Xu M, Snyder EL, Tormey CA. Clinical trials for pathogen reduction in transfusion medicine: A review. Transfusion And Apheresis Science 2009, 41: 217-225. PMID: 19793679, DOI: 10.1016/j.transci.2009.09.008.Peer-Reviewed Original ResearchConceptsClinical trialsBlood productsDonor screening programsDonor blood productsRisk of transmissionInfective donorsTransfusion recipientsScreening programClinical settingInfectious diseasesTransfusion medicineTesting regimensPI treatmentTrialsScreening assaysRiskPathogensPotential toxicityPromising strategyDetection of pathogensRegimensPathogen reductionSensitive methodDiseaseRecipientsChapter 42 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 42 Neonatal and Pediatric Transfusion Medicine. 2009, 235-239. DOI: 10.1016/b978-0-12-374432-6.00042-7.Peer-Reviewed Original ResearchCardiopulmonary diseaseSevere cardiopulmonary diseaseSmall-volume transfusionsFebrile transfusion reactionsPediatric transfusion medicineHLA alloimmunizationSymptomatic anemiaMajor surgeryPediatric patientsPremature infantsCMV transmissionTransfusion therapyNeonatal patientsPhysiologic changesTransfusion reactionsImmune systemNeonatesFetal periodAnticoagulant-preservative solutionInfantsTransfusionRBC productsTransfusion medicineDlPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply